Dr. Melissa Paoloni was appointed Executive Vice President and Chief Operating Officer in 2024, after joining OncoNano as the Senior Vice President of Corporate and Strategic Development in 2023. She leads our corporate operations, business development, alliance management, and strategic planning efforts as we continue to advance our assets further into the clinic. Melissa brings 20 years of expertise in strategic partnering and collaborations across a variety of organizations including biopharma, diagnostics, public-private partnerships, and academia. Her most recent role was as Vice President of Corporate Development and Eternal Alliances at Arcus Biosciences, where she led partnering efforts across the portfolio. Previously, she provided strategic organizational consulting to several large pharmaceutical companies across a variety of therapeutic areas, ran large scale research programs at University of California at San Francisco and the National Cancer Institute, and developed multiple consortia to support innovative drug development efforts. Her deep oncology experience guides our portfolio management activities, process improvements across the organization, and provides operational leadership to our growing team.

Dr. Paoloni received her Bachelors from Stanford University, her Doctorate in veterinary medicine from Tufts University, medical oncology residency training at University of Wisconsin-Madison, and completed a Masters in clinical research training at Duke University.